• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用脉冲场凝胶电泳增强恶性淋巴瘤中t(14;18)易位的检测。

Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis.

作者信息

Zelenetz A D, Chu G, Galili N, Bangs C D, Horning S J, Donlon T A, Cleary M L, Levy R

机构信息

Department of Medicine, Stanford Medical School, CA.

出版信息

Blood. 1991 Sep 15;78(6):1552-60.

PMID:1884022
Abstract

The t(14;18) chromosomal translocation that results in the juxtaposition of the bcl-2 proto-oncogene with the heavy chain JH locus is a common cytogenetic abnormality in human lymphoma. In particular, it is seen in about 85% of follicular lymphoma (FL) and up to one-third of diffuse lymphomas (DL). The chromosome 18 breakpoints have been shown to cluster into two regions. The major breakpoint region (mbr) within the 3' untranslated region of the bcl-2 proto-oncogene accounts for approximately 60% of the cases and the minor cluster region (mcr) 30 kb 3' of bcl-2 accounts for approximately 25% of the breakpoints. Because of variability in the position of the breakpoint, detection of the t(14;18) by Southern blot analysis provides an important clonal marker for the tumor. However, conventional electrophoresis (CE) fails to detect the translocation in 15% to 25% of cases. We have applied pulsed-field gel electrophoresis (PFGE) to the detection of the t(14;18) in a series of lymphoma prospectively analyzed by CE, polymerase chain reaction (PCR), and cytogenetic analysis. PFGE readily detected t(14;18) rearrangements as indicated by comigration of bands detected with probes for the mbr region (chromosome 18) and the JH locus (chromosome 14). In a series of 40 patients with FL, this method proved to be the most comprehensive for detection of the translocation compared with standard methods; in fact, in one case only PFGE was able to detect the chromosomal rearrangement. Ten percent of the FL cases were negative by all methods tested. In a separate analysis of matched tissue specimens from cases of tumor progression of FL to diffuse lymphoma, PFGE detected a common t(14;18) rearrangement confirming a clonal origin in seven of seven cases, whereas CE detected a rearrangement in only three of seven cases. Overall, PFGE was able to detect a translocation in 8 of 12 cases that were negative by CE and four of eight negative by cytogenetic analysis. In conclusion, PFGE analysis is more comprehensive than CE, PCR, and cytogenetic analysis for the detection of the t(14;18) breakpoint in tissue biopsies of malignant lymphoma.

摘要

导致bcl-2原癌基因与重链JH基因座并列的t(14;18)染色体易位是人类淋巴瘤中常见的细胞遗传学异常。特别是,在约85%的滤泡性淋巴瘤(FL)和高达三分之一的弥漫性淋巴瘤(DL)中可见。18号染色体的断点已被证明聚集在两个区域。bcl-2原癌基因3'非翻译区内的主要断点区域(mbr)约占病例的60%,bcl-2下游30 kb的次要聚类区域(mcr)约占断点的25%。由于断点位置的变异性,通过Southern印迹分析检测t(14;18)可为肿瘤提供重要的克隆标记。然而,传统电泳(CE)在15%至25%的病例中未能检测到这种易位。我们将脉冲场凝胶电泳(PFGE)应用于一系列淋巴瘤中t(14;18)的检测,这些淋巴瘤通过CE、聚合酶链反应(PCR)和细胞遗传学分析进行前瞻性分析。PFGE很容易检测到t(14;18)重排,表现为用mbr区域(18号染色体)和JH基因座(14号染色体)探针检测到的条带共迁移。在一系列40例FL患者中,与标准方法相比,该方法被证明是检测易位最全面的方法;事实上,在1例中只有PFGE能够检测到染色体重排。10%的FL病例通过所有测试方法均为阴性。在对FL进展为弥漫性淋巴瘤病例的匹配组织标本进行的单独分析中,PFGE在7例中的7例中检测到常见的t(14;18)重排,证实了克隆起源,而CE仅在7例中的3例中检测到重排。总体而言,PFGE能够在CE检测为阴性的12例中的8例以及细胞遗传学分析检测为阴性的8例中的4例中检测到易位。总之,对于恶性淋巴瘤组织活检中t(14;18)断点的检测,PFGE分析比CE、PCR和细胞遗传学分析更全面。

相似文献

1
Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis.使用脉冲场凝胶电泳增强恶性淋巴瘤中t(14;18)易位的检测。
Blood. 1991 Sep 15;78(6):1552-60.
2
Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.伴有绒毛状淋巴细胞的脾淋巴瘤:BCL-1重排及细胞周期蛋白D1基因表达分析
Blood. 1994 Jun 15;83(12):3664-71.
3
A 1-kb Bcl-2-PCR fragment detection in a patient with follicular lymphoma and development of a new diagnostic PCR method.在一名滤泡性淋巴瘤患者中检测到1kb的Bcl-2-PCR片段并开发了一种新的诊断性PCR方法。
Diagn Mol Pathol. 2001 Jun;10(2):89-94. doi: 10.1097/00019606-200106000-00003.
4
Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets.通过聚合酶链反应扩增长靶标对t(14;18)(q32;q21)中BCL2/免疫球蛋白重链融合基因进行优化
Genes Chromosomes Cancer. 1998 Jan;21(1):17-29. doi: 10.1002/(sici)1098-2264(199801)21:1<17::aid-gcc4>3.0.co;2-b.
5
Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.原发性皮肤B细胞淋巴瘤中不存在t(14;18)染色体易位。
Br J Dermatol. 2001 Apr;144(4):735-44. doi: 10.1046/j.1365-2133.2001.04128.x.
6
Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma.细胞遗传学分析、Southern印迹分析及聚合酶链反应检测滤泡性淋巴瘤中t(14;18)的比较
Am J Clin Pathol. 1995 Apr;103(4):472-8. doi: 10.1093/ajcp/103.4.472.
7
Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new cluster.滤泡性淋巴瘤中BCL2-JH重排的特征:3' BCL2断点的PCR检测及一个新簇集的证据
Leukemia. 2000 Sep;14(9):1563-9. doi: 10.1038/sj.leu.2401889.
8
Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.针对t(14;18)连接序列的寡核苷酸克隆特异性探针:评估滤泡性淋巴瘤微小残留病的新工具。
Br J Haematol. 1996 Sep;94(4):676-84. doi: 10.1046/j.1365-2141.1996.7062323.x.
9
A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma.在人类滤泡性淋巴瘤中,14号染色体的亚显微间隙缺失经常发生在t(14;18)易位断点附近。
Genes Chromosomes Cancer. 1993 Mar;6(3):140-50. doi: 10.1002/gcc.2870060303.
10
t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.t(14;18)阴性滤泡性淋巴瘤与替代断点区域BCL6重排的高频率相关。
Mod Pathol. 2009 Sep;22(9):1251-7. doi: 10.1038/modpathol.2009.81. Epub 2009 May 22.

引用本文的文献

1
Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.淋巴细胞恶性肿瘤患者的抗体治疗:过去与现在
Int J Mol Sci. 2025 Feb 17;26(4):1711. doi: 10.3390/ijms26041711.
2
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment.滤泡性淋巴瘤诊断时的 EZH2 突变:指导一线治疗的有前途的生物标志物。
BMC Cancer. 2022 Sep 14;22(1):982. doi: 10.1186/s12885-022-10070-z.
3
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.维奈克拉联合 R-或 G-CHOP 方案治疗非霍奇金淋巴瘤:CAVALLI 期 1b 试验结果。
Blood. 2019 May 2;133(18):1964-1976. doi: 10.1182/blood-2018-11-880526. Epub 2019 Mar 8.
4
Chromatin modifying gene mutations in follicular lymphoma.滤泡性淋巴瘤中的染色质修饰基因突变。
Blood. 2018 Feb 8;131(6):595-604. doi: 10.1182/blood-2017-08-737361. Epub 2017 Nov 20.
5
loss cooperates with overexpression to promote lymphoma in mice.缺失与过表达协同作用促进小鼠淋巴瘤发生。
Blood. 2017 May 11;129(19):2645-2656. doi: 10.1182/blood-2016-08-733469. Epub 2017 Mar 13.
6
Somatic mosaicism: on the road to cancer.体细胞嵌合体:癌症之路。
Nat Rev Cancer. 2016 Jan;16(1):43-55. doi: 10.1038/nrc.2015.1. Epub 2015 Dec 18.
7
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.早期滤泡性淋巴瘤祖细胞中的突变与抗原呈递受抑制有关。
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1116-25. doi: 10.1073/pnas.1501199112. Epub 2015 Feb 23.
8
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.滤泡性淋巴瘤基因组进化和进展过程中体细胞突变的层次结构。
Blood. 2013 Feb 28;121(9):1604-11. doi: 10.1182/blood-2012-09-457283. Epub 2013 Jan 7.
9
''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.滤泡性淋巴瘤中的“微小”BCL2断点:236例病例的频率及其与分级和疾病表现的相关性
J Mol Diagn. 2007 Sep;9(4):530-7. doi: 10.2353/jmoldx.2007.070038. Epub 2007 Jul 25.
10
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.改变的B细胞受体信号动力学将人类滤泡性淋巴瘤B细胞与肿瘤浸润的非恶性B细胞区分开来。
Blood. 2006 Nov 1;108(9):3135-42. doi: 10.1182/blood-2006-02-003921. Epub 2006 Jul 11.